A prospective study of the use of circulating markers as predictors for epidermal growth factor receptor-tyrosine kinase inhibitor treatment in pulmonary adenocarcinoma-Reference-Cited by-同舟云学术

A prospective study of the use of circulating markers as predictors for epidermal growth factor receptor-tyrosine kinase inhibitor treatment in pulmonary adenocarcinoma

Published:2016-01-18 Issue:1 Volume:16 Page:19-29
ISSN:1574-0153
Container-title:Cancer Biomarkers
language:
Short-container-title:CBM

Author:

Luo Yung-Hung¹²,Tseng Pei-Chun¹,Lee Yu-Chin¹²³,Perng Reury-Perng¹,Whang-Peng Jacqueline⁴,Chen Yuh-Min¹²⁴

Affiliation:

1. Department of Chest Medicine, Taipei Veterans General Hospital, Taipei, Taiwan

2. School of Medicine, National Yang-Ming University, Taipei, Taiwan

3. Sijhih Cathay General Hospital, Taipei, Taiwan

4. Taipei Cancer Center, Taipei Medical University, Taipei, Taiwan

Publisher

IOS Press

Subject

Cancer Research,Genetics,Oncology,General Medicine

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. State-of-the-Art Molecular Oncology of Lung Cancer in Taiwan;International Journal of Molecular Sciences;2022-06-24

2. EXPRESSION AND SIGNIFICANCE OF CD133+CELLS IN PERIPHERAL BLOOD IN PATIENTS WITH ACUTE CEREBRAL INFARCTION;ACTA MEDICA MEDITERR;2022

3. Plasma Level of Circular RNA hsa_circ_0000190 Correlates with Tumor Progression and Poor Treatment Response in Advanced Lung Cancers;Cancers;2020-06-30

4. Association Between Residential Greenness and Cardiovascular Disease Risk;Journal of the American Heart Association;2018-12-18

5. Factors associated with efficacy of first-generation epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer;Tumor Biology;2017-05